Intravascular catheter-associated Staphylococcus aureus bacteremia (SAB) is an epidemic disease encountered in modern medical practice. Clinicians treating this infection must estimate the risk for hematogenous seeding of host tissues by S. aureus. This bedside judgment forms the basis for a variety of management decisions that have important implications for the patient and for health care costs.
Bacterial seeding is likely to be determined by a combination of host and bacterial factors. Several bacterial factors, including toxins, secreted exoproteins, and cell and the University of Oxford were followed in conducting the clinical research reported here. Daily reports were received from the microbiology laboratory documenting all patients at DUMC with clinical evidence of infection and у1 blood culture positive for S. aureus. Clinical data were collected at the time of the first positive blood culture result. Exclusion criteria included being an outpatient, being !18 years old, the presence of polymicrobial infection, an absolute neutrophil count of !1.0 ϫ 10 9 cells/L, or death before evaluation. Outcomes for all study patients were obtained 12 weeks after the initial positive blood culture results were obtained. Only data from the initial episode of bacteremia for each patient was included in this investigation.
Isolation and characterization of isolates. Bloodstream isolates from consecutive patients with SAB caused by an infected intravascular catheter from September 1994 through March 2001 were included in the current analysis. S. aureus isolates were stored at Ϫ70ЊC from the time of identification until they were tested in the current investigation.
Study definitions. The duration of symptoms was defined as the interval between the patient-reported onset of symptoms and the date of the initial blood culture positive for S. aureus. Time to effective antibiotic therapy was defined as the time, in days, from the initial blood culture positive for S. aureus to the initiation of effective parenteral therapy. Health care-associated bacteremia was defined according to standard definitions [7, 8] ; community-acquisition was defined as catheterassociated bacteremia acquired by patients living in their own home. An intravascular catheter was considered to be the portal of entry if inflammation was present around the catheter insertion site or if a catheter-tip culture was positive for S. aureus and no other source was evident [9] . Patients were further defined as having either hematogenous complications (HCs) or uncomplicated bacteremia. HC was defined as the presence of infective endocarditis (IE), septic arthritis, or vertebral osteomyelitis caused by hematogenous seeding of the infected site, either at the time of initial hospitalization or during the 12 weeks after the initial positive blood culture result. All HCs were independently confirmed by radiologic imaging, culture of S. aureus from a normally sterile site, or the use of the Duke diagnostic criteria for IE [10] . Uncomplicated bacteremia was defined as catheter-associated bacteremia without any of the above complications for 12 weeks after the initial positive blood culture result. Two types of permanent foreign bodies were defined in the population studied: first, long-term intravascular catheters (e.g., tunneled cuffed intravascular catheter or subcutaneous port catheter), and second, noncatheter devices (including pacemakers and/or defibrillators, prosthetic heart valves, orthopedic devices, and other permanent implants).
Evaluation of bacterial factors. A total of 35 determinants were evaluated by investigators blinded to any clinical or patient information. Of these determinants, 30 were evaluated using PCR and 5 (a-toxin, b-toxin, d-toxin, coagulase, and methicillin resistance) were assessed using phenotypic tests, as described elsewhere [5] . Methicillin susceptibility was determined using the oxacillin disk test, performed as specified by NCCLS and confirmed by MIC testing using frozen reference panels (Trek Diagnostics). The presence of the gene encoding chemotaxis inhibitory protein (i.e., the chp gene) was determined using primers designed using GenBank accession number AF285146 (forward primer, 5 -TTTTTAACGGCAGGAATC-3 ; reverse primer, 5 -TTGGCAAGTTATGAAATGTCT-3 ). PCR cycling conditions were 34 cycles at 96ЊC for 1 min, 58ЊC for 1 min, and 72ЊC for 2 min. PCR was otherwise performed using primers and conditions described elsewhere [5] .
Statistical methods. Stata software, version 8.1 (StataCorp) was used for all statistical analyses. Continuous variables were compared between groups by use of the Student's t test or the Kruskal-Wallis H test, as indicated, with an OR per unit derived using bivariable logistic regression analysis. Contingency tables were used to compare proportions between groups, with a relative risk (RR) and 95% CI calculated for the effect of each explanatory variable. Summary statistics were generated for each strain, consisting of the sum of putative bacterial virulence factors and bacterial factors previously shown to be associated with virulence. These were compared between groups by use of the Kruskal-Wallis H test. Logistic regression analysis was used to model the effects of multiple explanatory variables on our primary outcome of interest (i.e., HCs) and to explore their independence. The initial multivariable model included variables that were associated with the outcome and that had P values of !.1 on bivariable analysis. Variables were removed in a stepwise manner, and final associations were recorded as ORs with 95% CIs. The significance of factors and interactions between factors was investigated using likelihood ratio tests to compare the differences in log likelihoods between models with and without each factor.
RESULTS

Patient characteristics.
Catheter-associated SAB was found in 324 consecutive patients over the 91-month period. The source of bacteremia was presumed to be a tunneled cuffed intravascular catheter (e.g., Permcath or Hickman catheter) in 144 patients (44.4%), a temporary central venous catheter in 83 patients (25.6%), a peripheral vascular catheter in 46 patients (14.2%), a peripherally inserted central catheter in 19 patients (5.9%), a subcutaneous port catheter in 17 patients (5.2%), an intraaortic balloon pump in 8 patients (2.5%), and an arterial catheter in 7 patients (2.2%). By definition [7] , all 324 patients had health care-associated bacteremia; 180 bloodstream isolates (56%) were associated with hospital-or nursing homeacquired infections. Forty-two patients (13%) had HCs; 31 patients had endocarditis, 11 had septic arthritis, and 7 had ver- [43] ; also shown to recognize fibrinogen [44] 279 (98.9) 42 (100) … … clfA Adhesin for fibrinogen [45] ; mediates platelet activation and aggregation [46] 282 (100) 42 (100) … … clfB Adhesin for fibrinogen [45] ; mediates platelet activation and aggregation [46] ; mediates binding to epidermal cytokeratin [47] 282 (100) 
Multivariable analysis of host and bacterial factors present at the time of initial bacteremia and associated with HC.
On the basis of their association on bivariable analysis, the following host and bacterial characteristics were included as initial independent variables in a multivariable model in which the dependent variable was the presence of HC: presence of permanent foreign body, duration of symptoms before diagnosis, community onset, hemodialysis dependence, APACHE II score, methicillin resistance, and presence of diabetes. A significant positive association was noted between hemodialysis dependence and the presence of a foreign body. Because a significant statistical interaction in relation to outcome was also noted between the 2 variables, an interaction term was included in the multivariable analysis. With use of backward stepwise elimination, the presence of diabetes, community onset, and APACHE II score were dropped from the model. In the final multivariable model (table 3) , the duration of symptoms before diagnosis, the presence of a permanent foreign body, hemodialysis dependence, methicillin resistance, and the interaction term of concurrent permanent foreign body and hemodialysis dependence remained independently associated with HC. The area under the receiver operating characteristic curve for this final model was 0.81.
Two types of permanent foreign bodies existed in the population studied: first, long-term catheters serving as portals of entry (in 161 patients), and second, noncatheter devices at risk for hematogenous seeding (in 42 patients). When the multivariate model was repeated with the variable "permanent foreign body" divided into these 2 separate device-associated variables, both long-term catheter (OR, 4.50; 95% CI, 1.16-17.5;
) and noncatheter prosthesis (OR, 6.22; 95% CI, 2.16-P p .03 19.9;
) were independently associated with HC. P p .001 Multivariable analysis of HC: addition of treatment-related variables. A further multivariable analysis was performed to account for the potential impact of treatment-related variables on the risk for HC. In this analysis, we added the following variables to the initial multivariable analysis: time to effective antibiotic therapy, failure to remove catheter after positive blood culture result, and the interaction term "methicillin resistance and failure to remove a catheter" (because the 2 variables were positively associated). All significant variables from the original model remained significant when these additional treatment-related variables were added to the initial model. Although the time to effective therapy and the interaction term were not significant, failure to remove the catheter remained a significant risk for hematogenous spread (RR, 8.99; 95% CI, 2.15-37.5; ). P p .003 The multivariable analysis also identified a patient population at low risk for complications. Among patients with intravascular catheter-associated SAB with neither hemodialysis nor a permanent foreign body (i.e., long-term catheter or noncatheter prosthesis), the rate of HC was 2.4% (range, 0.5%-6.9%).
DISCUSSION
The clinical severity and outcome of S. aureus infection in a given individual is likely to be dictated by a complex interplay between host and pathogen. The study of bacterial pathogenesis is further complicated by the heterogeneity of S. aureus infections. This study of consecutive patients with a single type of S. aureus infection addresses such issues and has highlighted several risk factors for HC in patients with catheterassociated SAB.
Methicillin resistance, present in more than one-third of the isolates cultured from blood specimens in this study, was independently associated with an increased risk for HC. This association persisted even after adjustment for patient comorbid conditions with use of APACHE II scores. This finding is consistent with some prior clinical reports [11] [12] [13] [14] [15] [16] but is not consistent with others [17] [18] [19] [20] . There are several potential explanations for this observation. The genetic complement of MRSA isolates, and in particular the accessory genes, may produce a more virulent phenotype in cases of catheter-associated bacteremia. Consistent with this explanation are our findings that MRSA isolates associated with infection contained a distinct genetic virulence repertoire (e.g., had higher carriage of sea) and were more clonally restricted than were MSSA isolates, according to PFGE analysis (data not shown). Earlier in vitro studies have demonstrated no difference in virulence between MRSA and MSSA [21] [22] [23] [24] [25] . However, the current investigation is the first to simultaneously consider both patient and bacterial factors in a large collection of S. aureus isolates associated with a single infection type, making this study more reflective of the clinical interactions leading to HC than others. It is also possible that MRSA-infected patients had higher rates of HC because of treatment with vancomycin, which has been associated with high rates of clinical failure [26] , prolonged bacteremia [27] , and relapse [28] [29] [30] . These findings support additional studies to define the role of alternatives to vancomycin (e.g., daptomycin or linezolid) in the empirical treatment of infection due to S. aureus.
The presence of a permanent foreign body was also an independent predictor of HC in this study. This was true independently for both long-term catheters (which are potential portals of entry into the blood stream for infecting bacteria) and noncatheter devices (which can serve as a focus for hematogenous spread). This observation is consistent with prior reports documenting high rates of seeding by S. aureus in a variety of noncatheter devices [31] [32] [33] [34] . However, the current investigation is the first to document the high risk of HC among patients with long-term indwelling catheters, even when compared with patients with SAB caused by other types of vascular catheters. This finding may be explained in part by the diagnostic and therapeutic delay associated with the patient's community residence and/or with reluctance to remove the longterm vascular access. The high rate of foreign body infection in this study may also be explained in part by the fact that bacterial characteristics involved in catheter-associated sepsis are also integral determinants of other forms of device-associated infection. For example, rates of cna and icaA in the current study were significantly higher than in our previous study [5] , which primarily involved isolates that were not associated with catheter infection.
Although previous studies have reported high rates of complications among hemodialysis -dependent patients [35] , before the current investigation, it was unclear whether this was related to the presence of chronic intravascular access or to the direct effects of hemodialysis on host susceptibility to staphylococcal infection. The current investigation demonstrates that hemodialysis dependence is an independent risk factor for HC, even among patients with catheter-associated SAB. This elevated risk may be related to the impact of hemodialysis on host immunity, including uremia-associated phagocyte dysfunction [36] and iron overload [37, 38] .
The current investigation also documents that the failure to remove or the delay in removal of an infected catheter is an independent risk factor for HC. These findings are consistent with published guidelines for the treatment of catheter-associated infections [39, 40] and emphasize the importance of prompt removal if such catheters are believed to be the source of an episode of SAB.
The current investigation supports the use of microarray technology to further pursue the impact of bacterial characteristics on disease severity, because it is possible that the bacterial factors influencing the risk for hematogenous seeding have simply not yet been characterized. For example, DNA microarray analysis of 36 clonally diverse S. aureus strains identified 10 large regions of difference with numerous genes encoding previously unknown putative virulence factors [41] . In addition, the genome of an isolate of community-acquired MRSA (i.e., MW2) was shown to have 18 toxins not present within any of 5 S. aureus genomes with which it was compared [42] . The combination of genetic diversity and rapid genetic exchange could give rise to particular S. aureus phenotypes that are better equipped than others for invasion of the human host. Indeed, the increased risk for hematogenous seeding found among the study patients with MRSA bacteremia suggests that as-yet-unidentified factors can enhance the virulence properties of these clonal strains.
Our investigation had limitations. We were unable to evaluate the impact of conditions such as necrotic bone and osteoarthritis, because these conditions were not systematically sought (e.g., by diagnostic imaging) in all study patients by the treating physicians, potentially biasing the recognition of these conditions. In addition, our sample size limited our ability to fully evaluate multiple host characteristics that were unrelated to the intravascular catheter. Finally, the study was conducted at a single tertiary care center. Thus, confirmation of these findings with use of geographically diverse patients and isolates is required.
In conclusion, SAB associated with intravascular devices is a serious, common complication of medical progress. This study has defined 4 clinically relevant factors for HC of catheterassociated SAB and has provided evidence suggesting heightened virulence among MRSA strains isolated from the bloodstream. Further investigations are required to clarify the impact of virulence characteristics of individual S. aureus strains on the outcome of infection.
